Literature DB >> 6712769

A new isoform of apolipoprotein E--apo E-5--associated with hyperlipidemia and atherosclerosis.

T Yamamura, A Yamamoto, K Hiramori, S Nambu.   

Abstract

Heterogeneity of apolipoprotein E (apo E) was analyzed by isoelectric focusing of apo VLDL in patients with hyperlipidemia and/or atherosclerosis. Six major apo E phenotypes were shown, in agreement with the current genetic model which is composed of 3 major apo E isoproteins, apo E-4, apo E-3 and apo E-2, resulting from three apo E alleles, epsilon 4, epsilon 3 and epsilon 2, at a single genetic locus. We recognized an additional apolipoprotein band, which is located basic to apo E-4 on an isoelectric focusing gel, in 3 patients with hyperlipidemia. The new apolipoprotein component, named apo E-5, was identical with ordinary apo E in apparent molecular weight by SDS-polyacrylamide gel electrophoresis and in its interactions with heparin-Sepharose gel and with anti-apo E antibody. This mutant apo E isoprotein had an isoelectric point more basic by one unit of charge than apo E-4. Two of 3 patients had the phenotype E5/3, and the other the phenotype E5/4. Genetic analysis of the apo E phenotypes in family members of the patients indicated the presence of a new apo E allele (epsilon 5) at the same genetic locus as hitherto known alleles. Since most of the subjects above 50 years old with apo E-5 had ischemic heart disease or cerebral infarction, it was suggested that the mutant apo E-5 may possibly be related to the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712769     DOI: 10.1016/0021-9150(84)90019-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels.

Authors:  M Smit; P de Knijff; M Rosseneu; J Bury; E Klasen; R Frants; L Havekes
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

2.  Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.

Authors:  M R Wardell; S O Brennan; E D Janus; R Fraser; R W Carrell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

Review 3.  Implications of Necroptosis for Cardiovascular Diseases.

Authors:  Zhao-Hui Ruan; Zi-Xuan Xu; Xue-Yun Zhou; Xian Zhang; Lei Shang
Journal:  Curr Med Sci       Date:  2019-07-25

4.  New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.

Authors:  T Yamamura; A Yamamoto; T Sumiyoshi; K Hiramori; Y Nishioeda; S Nambu
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

5.  Familial disorders of plasma apolipoproteins.

Authors:  C R Sirtori; G Franceschini
Journal:  Klin Wochenschr       Date:  1985-06-03

6.  Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.

Authors:  L Havekes; E de Wit; J G Leuven; E Klasen; G Utermann; W Weber; U Beisiegel
Journal:  Hum Genet       Date:  1986-06       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.